What the business is, and whether it's a good one at a fair price.
A Chemicals & Petrochemicals company listed on NSE and BSE, reporting revenue of ₹950 Cr over the trailing twelve months.
Measured from the filed financials, judged against its Dyes And Pigments peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from KIRI INDUSTRIES LIMITED's filed financials and exchange disclosures
KIRI INDUSTRIES LIMITED is a Chemicals & Petrochemicals company listed on NSE and BSE, trading under the symbol KIRIINDUS.
Yes. Over the trailing twelve months KIRI INDUSTRIES LIMITED reported a net profit of ₹5,848 Cr on revenue of ₹950 Cr.
Not in the latest reported year — KIRI INDUSTRIES LIMITED's dividend payout for FY26 was nil.
Effectively yes. It holds ₹511 Cr more cash than debt. Debt stands at 0.01× equity.
On trailing P/E, KIRI INDUSTRIES LIMITED ranks 1 of 10 in Dyes And Pigments — cheaper than 100% of them, against an industry median of 19.8×. This is a position, not a valuation judgement.
On a typical session KIRI INDUSTRIES LIMITED moves 1.41% — that is the median absolute close-to-close move across its last 268 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by KIRI INDUSTRIES LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
